Laila - anxiety relief and sleep promotion medicament 28 soft capsules

Product Description

Treatment indicated for the relief of mild anxiety symptoms and to promote sleep.

Indications

Laila is a traditional herbal medicine indicated for the relief of mild anxiety symptoms and to promote sleep.
The use of this traditional herbal medicine, for the indicated therapeutic indications, is based exclusively on many years of experience.
Laila is indicated for adults and adolescents aged 12 years and over.

Composition

Active ingredients

1 soft capsule contains: 80 mg of Lavandula angustifolia Miller, aetheroleum (lavender essential oil).

Excipients

Capsule contents: Refined rapeseed oil. Capsule shell: Succinylated gelatin, Glycerol 85%, Non-crystallized sorbitol 70%, Titanium dioxide, Colouring agents: Carminic acid aluminium lake (E 120); Patent blue V aluminium lake (E 131).

Directions for use and Dosage

Adults and adolescents over 12 years of age take one soft capsule per day (corresponding to 80 mg of lavender essential oil per day).
Laila should not be used in children under 12 years of age.
Method of administration: Oral use.
The soft capsules should be swallowed whole with sufficient liquid (preferably a glass of water).
Duration of treatment If symptoms persist after two weeks of using the product, a doctor or qualified healthcare professional should be consulted.

Warnings

Use in children under 12 years of age has not been established due to insufficient data.
If symptoms worsen during use of the product, a doctor or qualified healthcare professional should be consulted.
Laila contains sorbitol.
Patients with rare hereditary problems of fructose intolerance should not take this medicine. Use in patients with impaired liver function is not recommended as they may cause liver damage. The components of lavender essence are largely eliminated by liver metabolism.

Interactions

Published data demonstrate that lavender essential oil (160 mg/day) has no clinically relevant inhibition or induction effects on CYP 1A2, 2C9, 2C19, 2D6, and 3A4 enzymes in humans. Furthermore, no clinically relevant impact of lavender essential oil on the contraceptive efficacy of combined oral contraceptives has been observed.

Pregnancy and lactation

Safety during pregnancy and lactation has not been established. In the absence of sufficient data, use during pregnancy and lactation is not recommended. No data on fertility are available.

Storage

Do not store above 30°C.

Format

28 soft capsules.